LU67790A1 - - Google Patents
Info
- Publication number
- LU67790A1 LU67790A1 LU67790A LU67790DA LU67790A1 LU 67790 A1 LU67790 A1 LU 67790A1 LU 67790 A LU67790 A LU 67790A LU 67790D A LU67790D A LU 67790DA LU 67790 A1 LU67790 A1 LU 67790A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU67790A1 true LU67790A1 (OSRAM) | 1973-08-16 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU67790A LU67790A1 (OSRAM) | 1972-06-15 | 1973-06-14 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (OSRAM) |
| CA (1) | CA1040619A (OSRAM) |
| DE (1) | DE2330342A1 (OSRAM) |
| DK (1) | DK136157B (OSRAM) |
| FR (1) | FR2189034B2 (OSRAM) |
| GB (1) | GB1434919A (OSRAM) |
| LU (1) | LU67790A1 (OSRAM) |
| NL (1) | NL7308267A (OSRAM) |
| ZA (1) | ZA734037B (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014256228C1 (en) | 2013-04-17 | 2017-09-14 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| RS58297B1 (sr) | 2013-04-17 | 2019-03-29 | Sage Therapeutics Inc | 19-nor c3,3-disupstituisani c21-n-pirazolil steroidi i postupci za njihovu upotrebu |
| BR112016000975B1 (pt) | 2013-07-19 | 2020-10-06 | Sage Therapeutics, Inc. | Compostos esteróides neuroativos e composições compreendendo os mesmos |
| RS61370B1 (sr) | 2013-08-23 | 2021-02-26 | Sage Therapeutics Inc | Neuroaktivni steroidi, njihove kompozicije i upotreba |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| CN118344424A (zh) | 2014-10-16 | 2024-07-16 | 萨奇治疗股份有限公司 | 靶向cns障碍的组合物和方法 |
| DK3206493T3 (da) | 2014-10-16 | 2020-08-10 | Sage Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser |
| SI3224269T1 (sl) | 2014-11-27 | 2020-10-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| ES2857082T3 (es) | 2015-01-26 | 2021-09-28 | Sage Therapeutics Inc | Composiciones y métodos para el tratamiento de trastornos del SNC |
| ES2935476T3 (es) | 2015-02-20 | 2023-03-07 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
| WO2018013615A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| AU2017297375B2 (en) | 2016-07-11 | 2022-09-15 | Sage Therapeutics, Inc. | C17, C20, and C21 substituted neuroactive steroids and their methods of use |
| BR112021024033A2 (pt) | 2019-05-31 | 2022-02-08 | Sage Therapeutics Inc | Esteroides neuroativos e suas composições |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| GB1380246A (en) * | 1970-12-17 | 1975-01-08 | Glaxo Lab Ltd | 3alpha-hydroxy-androstanes and esters thereof |
| FR2118117B1 (OSRAM) * | 1970-12-17 | 1975-12-26 | Glaxo Lab Ltd |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5693773A (en) | 1974-12-19 |
| DK136157C (OSRAM) | 1978-01-23 |
| BE800899R (fr) | 1973-12-14 |
| FR2189034B2 (OSRAM) | 1977-01-21 |
| CA1040619A (en) | 1978-10-17 |
| GB1434919A (en) | 1976-05-12 |
| DK136157B (da) | 1977-08-22 |
| DE2330342A1 (de) | 1974-01-17 |
| NL7308267A (OSRAM) | 1973-12-18 |
| FR2189034A2 (OSRAM) | 1974-01-25 |
| ZA734037B (en) | 1974-05-29 |